• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核小体去甲基化中的NPAC-LSD2复合物

The NPAC-LSD2 complex in nucleosome demethylation.

作者信息

Caroli Jonatan, Mattevi Andrea

机构信息

Department of Biology and Biotechnology "Lazzaro Spallanzani", University of Pavia, Pavia, Italy.

Department of Biology and Biotechnology "Lazzaro Spallanzani", University of Pavia, Pavia, Italy.

出版信息

Enzymes. 2023;53:97-111. doi: 10.1016/bs.enz.2023.03.003. Epub 2023 Apr 21.

DOI:10.1016/bs.enz.2023.03.003
PMID:37748839
Abstract

NPAC is a transcriptional co-activator widely associated with the H3K36me3 epigenetic marks present in the gene bodies. NPAC plays a fundamental role in RNA polymerase progression, and its depletion downregulates gene transcription. In this chapter, we review the current knowledge on the functional and structural features of this multi-domain protein. NPAC (also named GLYR1 or NP60) contains a PWWP motif, a chromatin binder and epigenetic reader that is proposed to weaken the DNA-histone contacts facilitating polymerase passage through the nucleosomes. The C-terminus of NPAC is a catalytically inactive dehydrogenase domain that forms a stable and rigid tetramer acting as an oligomerization module for the formation of co-transcriptional multimeric complexes. The PWWP and dehydrogenase domains are connected by a long, mostly disordered, linker that comprises putative sites for protein and DNA interactions. A short dodecapeptide sequence (residues 214-225) forms the binding site for LSD2, a flavin-dependent lysine-specific histone demethylase. This stretch of residues binds on the surface of LSD2 and facilitates the capture and processing of the H3 tail in the nucleosome context, thus promoting the H3K4me1/2 epigenetic mark removal. LSD2 is associated with other two chromatin modifiers, G9a and NSD3. The LSD2-G9a-NSD3 complex modifies the pattern of the post translational modifications deposited on histones, thus converting the relaxed chromatin into a transcriptionally refractory state after the RNA polymerase passage. NPAC is a scaffolding factor that organizes and coordinates the epigenetic activities required for optimal transcription elongation.

摘要

NPAC是一种转录共激活因子,广泛与基因体内存在的H3K36me3表观遗传标记相关。NPAC在RNA聚合酶进程中发挥着重要作用,其缺失会下调基因转录。在本章中,我们综述了关于这种多结构域蛋白的功能和结构特征的现有知识。NPAC(也称为GLYR1或NP60)包含一个PWWP基序,这是一种染色质结合剂和表观遗传阅读器,被认为可削弱DNA-组蛋白接触,促进聚合酶通过核小体。NPAC的C末端是一个无催化活性的脱氢酶结构域,它形成一个稳定且刚性的四聚体,作为共转录多聚体复合物形成的寡聚化模块。PWWP和脱氢酶结构域由一个长的、大多无序的连接子连接,该连接子包含蛋白质和DNA相互作用的假定位点。一个短的十二肽序列(第214 - 225位氨基酸残基)形成了LSD2(一种黄素依赖性赖氨酸特异性组蛋白去甲基化酶)的结合位点。这段氨基酸残基序列结合在LSD2的表面,促进在核小体环境中对H3尾巴的捕获和加工,从而促进H3K4me1/2表观遗传标记的去除。LSD2与另外两种染色质修饰剂G9a和NSD3相关联。LSD2 - G9a - NSD3复合物修饰沉积在组蛋白上的翻译后修饰模式,从而在RNA聚合酶通过后将松弛的染色质转变为转录难治状态。NPAC是一种支架因子,可组织和协调最佳转录延伸所需的表观遗传活动。

相似文献

1
The NPAC-LSD2 complex in nucleosome demethylation.核小体去甲基化中的NPAC-LSD2复合物
Enzymes. 2023;53:97-111. doi: 10.1016/bs.enz.2023.03.003. Epub 2023 Apr 21.
2
A Tail-Based Mechanism Drives Nucleosome Demethylation by the LSD2/NPAC Multimeric Complex.尾部机制驱动 LSD2/NPAC 多聚体复合物介导的核小体去甲基化。
Cell Rep. 2019 Apr 9;27(2):387-399.e7. doi: 10.1016/j.celrep.2019.03.061.
3
LSD2/KDM1B and its cofactor NPAC/GLYR1 endow a structural and molecular model for regulation of H3K4 demethylation.LSD2/KDM1B 及其辅助因子 NPAC/GLYR1 为 H3K4 去甲基化的调控提供了结构和分子模型。
Mol Cell. 2013 Feb 7;49(3):558-70. doi: 10.1016/j.molcel.2012.11.019. Epub 2012 Dec 20.
4
Evaluation of phenylcyclopropylamine compounds by enzymatic assay of lysine-specific demethylase 2 in the presence of NPAC peptide.在NPAC肽存在的情况下,通过赖氨酸特异性去甲基化酶2的酶促测定评估苯基环丙胺化合物。
Bioorg Med Chem Lett. 2016 Feb 15;26(4):1193-5. doi: 10.1016/j.bmcl.2016.01.036. Epub 2016 Jan 16.
5
Human LSD2/KDM1b/AOF1 regulates gene transcription by modulating intragenic H3K4me2 methylation.人类 LSD2/KDM1b/AOF1 通过调节基因内 H3K4me2 甲基化来调控基因转录。
Mol Cell. 2010 Jul 30;39(2):222-33. doi: 10.1016/j.molcel.2010.07.008.
6
Structure-function analysis reveals a novel mechanism for regulation of histone demethylase LSD2/AOF1/KDM1b.结构-功能分析揭示了组蛋白去甲基酶 LSD2/AOF1/KDM1b 调控的新机制。
Cell Res. 2013 Feb;23(2):225-41. doi: 10.1038/cr.2012.177. Epub 2012 Dec 25.
7
A novel mammalian flavin-dependent histone demethylase.一种新型的哺乳动物黄素依赖性组蛋白去甲基化酶。
J Biol Chem. 2009 Jun 26;284(26):17775-82. doi: 10.1074/jbc.M109.003087. Epub 2009 Apr 30.
8
The Role of LSD1 and LSD2 in Cancers of the Gastrointestinal System: An Update.LSD1 和 LSD2 在胃肠道系统癌症中的作用:最新进展。
Biomolecules. 2022 Mar 17;12(3):462. doi: 10.3390/biom12030462.
9
Crystal Structure of the LSD1/CoREST Histone Demethylase Bound to Its Nucleosome Substrate.与核小体底物结合的LSD1/CoREST组蛋白去甲基化酶的晶体结构。
Mol Cell. 2020 Jun 4;78(5):903-914.e4. doi: 10.1016/j.molcel.2020.04.019. Epub 2020 May 11.
10
Inhibition of histone demethylase, LSD2 (KDM1B), attenuates DNA methylation and increases sensitivity to DNMT inhibitor-induced apoptosis in breast cancer cells.组蛋白去甲基化酶LSD2(KDM1B)的抑制作用可减弱DNA甲基化,并增加乳腺癌细胞对DNA甲基转移酶抑制剂诱导的凋亡的敏感性。
Breast Cancer Res Treat. 2014 Jul;146(1):99-108. doi: 10.1007/s10549-014-3012-9. Epub 2014 Jun 13.

引用本文的文献

1
LSD2 Is an Epigenetic Player in Multiple Types of Cancer and Beyond.LSD2 在多种癌症及其他疾病中是一种表观遗传调控因子。
Biomolecules. 2024 May 3;14(5):553. doi: 10.3390/biom14050553.